URINARY-EXCRETION OF PLATELET-ACTIVATING-FACTOR IN HEMOLYTIC UREMIC SYNDROME

被引：21

作者：

BENIGNI, A

BOCCARDO, P

NORIS, M

REMUZZI, G

SIEGLER, RL

机构：

[1] UNIV UTAH,DEPT PEDIAT,DIV NEPHROL & HYPERTENS,50 N MED DR,SALT LAKE CITY,UT 84132

[2] OSPED RIUNITI BERGAMO,DIV NEPHROL,I-24100 BERGAMO,ITALY

[3] MARIO NEGRI INST PHARMACOL RES,BERGAMO,ITALY

来源：

LANCET | 1992年 / 339卷 / 8797期

关键词：

D O I：

10.1016/0140-6736(92)90281-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Since some of the features of haemolytic uraemic syndrome (HUS), such as platelet activation and glomerular injury, could be brought about by platelet-activating factor (PAF), we have studied the urinary excretion of PAF in 10 children with HUS and in 10 healthy age-matched controls. Urinary PAF concentrations, measured by radioimmunoassay, were significantly higher in acute-phase HUS patients than in controls (mean 2.04 [SD 1.66] vs 0.72 [0.43] ng/mg creatinine, p < 0.05) but were similar to those in controls in samples taken after recovery. High PAF concentrations during the acute phase of HUS may reflect platelet activation and glomerular injury, the lower values after recovery suggest that urinary PAF may be a marker of disease activity.

引用

页码：835 / 836

页数：2

共 8 条

[1]

APPIANI AC, 1982, CLIN NEPHROL, V17, P195

[2] POTENTIAL ROLE OF PLATELET-ACTIVATING-FACTOR IN RENAL PATHOPHYSIOLOGY [J].